KINETICOS DISRUPTOR FUND
Kineticos Disruptor Fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies. The Fund will focus on large, unmet medical needs in oncology, neurosciences, and rare diseases. In oncology, new approaches to solid tumors and โoff the shelfโ allogeneic cell therapies are immediate priorities.
Similar Organizations
Avoro Capital Advisors
Avoro Capital Advisors is a global life sciences investment firm.
BioBrit
Founded in 2012, BioBrit is a life sciences consulting and investment firm located in La Jolla, California.
HAT Technology & Innovation Fund
HAT Technology & Innovation Fund is a reserved closed-end alternative investment fund.
My Climate Journey Collective
My Climate Journey Collective is an early-stage climate tech fund.
Neo Kuma Ventures
Psychedelic Healthcare Investment Fund
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-14 | Inceptor Bio | Kineticos Disruptor Fund investment in Seed Round - Inceptor Bio | 26 M USD |
2020-05-28 | Promaxo | Kineticos Disruptor Fund investment in Series B - Promaxo | 10.97 M USD |
More informations about "Kineticos Disruptor Fund"
Kineticos Disruptor Fund - Crunchbase
Kineticos Disruptor Fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related โฆSee details»
Kineticos Disruptor Fund Leads Promaxoโs Series B-1 Funding Round
The Kineticos Disruptor Fund will focus on large, unmet medical needs in oncology, neurosciences and rare diseases. ... Kineticos is an award-winning organization supporting โฆSee details»
Kineticos | Life Sciences Firm
Jan 23, 2024 Kineticos Life Sciences Announces Successful Final Close of approximately $60 Million for Kineticos Disruptor Fund II RALEIGH, N.C. | Novemberโฆ Press Release July 26, โฆSee details»
Kineticos Announces New Life Sciences Disruptor Fund That Will โฆ
Feb 6, 2020 The Kineticos Disruptor Fund will focus on large, unmet medical needs in oncology, neurosciences and rare diseases. In oncology, new approaches to solid tumors and "off the โฆSee details»
Experic Closes $14 Million Series B Financing - Experic
CRANBURY, N.J.; November 30, 2022 (Business Wire) โ Experic, a contract development and manufacturing organization (CDMO) ... Kineticos Ventures, through its Kineticos Disruptor โฆSee details»
Kineticos Disruptor Fund II: Performance - PitchBook
May 30, 2023 Kineticos Disruptor Fund II's latest investment was on 26-Mar-2024 in EnteroBiotix, a company within the Drug Discovery industry. Data Transparency. Meet our โฆSee details»
Kineticos Disruptor Fund: Performance - PitchBook
Kineticos Disruptor Fund was a venture capital fund led by Kineticos Life Sciences. The fund was located in Raleigh, North Carolina. The fund invests in biotechnology, life sciences and โฆSee details»
Kineticos Disruptor Fund - Funding, Financials, Valuation & Investors
Kineticos Disruptor Fund has raised a total of $5.5M in a single venture fund, Kineticos Disruptor Fund IB8. This fund was announced on Jul 15, 2021 and raised a total of . obfuscated. โฆSee details»
Kineticos Disruptor Fund: Drug pipelines, Patents, Clinical trials ...
Explore Kineticos Disruptor Fund with its drug pipeline, therapeutic area, technology platform, 6 news. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign Up for Free. Last update โฆSee details»
Kineticos Life Sciences Announces Successful Final โฆ
RALEIGH, N.C. | November 17, 2023 โ Kineticos Life Sciences is pleased to announce the successful final close of Kineticos Disruptor Fund II (KDF II or the Fund) with $57.3 million in committed capital. KDF II, a growth equity and โฆSee details»
Kineticos Disruptor Fund IB4 LLC - Drug pipelines, Patents, Clinical ...
Explore Kineticos Disruptor Fund IB4 LLC with its drug pipeline, therapeutic area, technology platform, . Biomedical products. Data. Feature. Plans. Sign Up for Free. Request Demo. Sign โฆSee details»
Kineticos Disruptor Fund KCB 10: Performance - PitchBook
Kineticos Disruptor Fund Kcb10 is an early-stage venture capital fund managed by Kineticos Life Sciences Management. The fund is located in Raleigh, North Carolina. Contact InformationSee details»
Kineticos Disruptor Fund - Investments, Portfolio & Company Exits
Jun 14, 2021 Kineticos Disruptor Fund has made 2 investments. Their most recent investment was on Jun 14, 2021, ... obfuscated. How many investments has this organization made over โฆSee details»
Scottish Life Sciences Gains Investment Boost from Strategic
Feb 15, 2021 Shailesh Maingi, Founder and Chairman of Kineticos, said: โThe Kineticos Disruptor Fundโs mission is simple: to find cures for difficult to treat cancers and rare diseases. โฆSee details»
Kineticos Disruptor Fund XM11: Performance - PitchBook
Kineticos Disruptor Fund XM11 is a private equity growth expansion fund managed by Kineticos Ventures. The fund is located in Raleigh, North Carolina. Contact InformationSee details»
Kineticos Disruptor Fund and Eos Advisory Form Partnership To โฆ
About Kineticos Disruptor Fund: You have ideas, we have funding. Through Kineticos and our related Kineticos Disruptor Fund, we invest in select sponsors to advance clinical research. โฆSee details»
Kineticos Disruptor Fund - Updates, News, Events, Signals & Triggers
Kineticos Disruptor Fund is a new life sciences investment fund. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. โฆSee details»
Kineticos Disruptor Fund - Unicorn Nest
Kineticos Disruptor Fund. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom โฆSee details»
Kineticos | Life Sciences Team, Partners & Advisors
The Kineticos team of financial, business, and scientific experts guides and accelerates its life sciences portfolio companies towards growth and success. ... He is a partner in the Kineticos โฆSee details»